geoopen
p38alpha and S1P-dependent SREBP2 activation by the SAM-competitive EZH2 inhibitor GSK343 limits its anticancer activity but creates a druggable vulnerability in hepatocellular carcinoma
GEO Series GSE129204. Homo sapiens. 12 samples. Type: Expression profiling by array.
ShareScore
20/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 4
- Harmonization
- 8
- Access
- 0
- Reuse readiness
- 0
- Engagement
- 8